These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37184158)

  • 1. The emerging role of the gut mycobiome in liver diseases.
    Szóstak N; Figlerowicz M; Philips A
    Gut Microbes; 2023; 15(1):2211922. PubMed ID: 37184158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut mycobiome: a novel player in chronic liver diseases.
    Jiang L; Stärkel P; Fan JG; Fouts DE; Bacher P; Schnabl B
    J Gastroenterol; 2021 Jan; 56(1):1-11. PubMed ID: 33151407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles for the mycobiome in liver disease.
    Zeng S; Schnabl B
    Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly.
    Zhang F; Aschenbrenner D; Yoo JY; Zuo T
    Lancet Microbe; 2022 Dec; 3(12):e969-e983. PubMed ID: 36182668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut mycobiome alterations and implications for liver diseases.
    Zeng S; Schnabl B
    PLoS Pathog; 2024 Aug; 20(8):e1012377. PubMed ID: 39116092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut mycobiome and metabolic diseases: The known, the unknown, and the future.
    Wang L; Zhang K; Zeng Y; Luo Y; Peng J; Zhang J; Kuang T; Fan G
    Pharmacol Res; 2023 Jul; 193():106807. PubMed ID: 37244385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
    Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
    Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fecal mycobiome in non-alcoholic fatty liver disease.
    Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
    J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication.
    Zhou X; Zhang X; Yu J
    Biomed J; 2024 Jun; 47(3):100625. PubMed ID: 37364760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobiome in the Gut: A Multiperspective Review.
    Chin VK; Yong VC; Chong PP; Amin Nordin S; Basir R; Abdullah M
    Mediators Inflamm; 2020; 2020():9560684. PubMed ID: 32322167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestinal mycobiome as a determinant of host immune and metabolic health.
    Gutierrez MW; Arrieta MC
    Curr Opin Microbiol; 2021 Aug; 62():8-13. PubMed ID: 33993019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forgotten fungi-the gut mycobiome in human health and disease.
    Huseyin CE; O'Toole PW; Cotter PD; Scanlan PD
    FEMS Microbiol Rev; 2017 Jul; 41(4):479-511. PubMed ID: 28430946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Early Life Gut Mycobiome on Child Health.
    Rodriguez KA; Gurung M; Talatala R; Rearick JR; Ruebel ML; Stephens KE; Yeruva L
    Adv Nutr; 2024 Mar; 15(3):100185. PubMed ID: 38311313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut mycobiome: The probable determinative role of fungi in IBD patients.
    Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
    Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterotypes of the human gut mycobiome.
    Lai S; Yan Y; Pu Y; Lin S; Qiu JG; Jiang BH; Keller MI; Wang M; Bork P; Chen WH; Zheng Y; Zhao XM
    Microbiome; 2023 Aug; 11(1):179. PubMed ID: 37563687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host.
    Sam QH; Chang MW; Chai LY
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations.
    Van Syoc E; Nixon MP; Silverman JD; Luo Y; Gonzalez FJ; Elbere I; Klovins J; Patterson AD; Rogers CJ; Ganda E
    mBio; 2024 Jun; 15(6):e0016924. PubMed ID: 38767350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.
    Fiedorová K; Radvanský M; Bosák J; Grombiříková H; Němcová E; Králíčková P; Černochová M; Kotásková I; Lexa M; Litzman J; Šmajs D; Freiberger T
    Front Immunol; 2019; 10():1914. PubMed ID: 31456808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.